Rare, for a reason
At Atlantic Research Group, we know how difficult it is to develop an orphan drug. But, we also know that great things happen when passionate people combine their strengths. Together, we create smart, feasible studies with protocols that reflect everyday life. We connect individuals—even if there are only 50 in the entire world with a particular rare disease—to organizations that have the drive and know-how to develop potential treatments. We uncover far-reaching insights in orphan drug research, no matter how limited data may be. Let’s unite and finish the journey from trial to treatment.
When we began our journey in 2004, we knew there was a better way. We found it.
Come see us at the SCOPE Summit 2017 in Miami, January 24-26! ARG will be hosting a hospitality suite in the Board Room of the Hyatt Regency, and will be featured throughout the event. Our VP of Product Development, John Boland, will be chairing sessions on Clinical Trial Forecasting and Budgeting, Establishing and Outsourcing Strategy, and Managing Outsourced Clinical Trials. We look forward to seeing you in Miami!
We specialize in the needs of agile and emerging biopharmaceutical companies
Start with one savvy business leader with a passion for execution, and another with passion for therapeutic technologies and the process of bringing them to market. Add an accomplished professor from one of the world’s most prestigious universities. These are the fundamental ingredients of Atlantic Research Group.
Hundreds of clinical trials encompassing tens of thousands of patients at over 5000 investigative sites.
Partnerships for biostatistics, pharmacovigilance, and safety.